P1100: BRUIN MCL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR CHOICE OF BTK INHIBITOR IN PATIENTS WITH PREVIOUSLY TREATED, BTK INHIBITOR NAÏVE MCL (TRIAL IN PROGRESS)

Detalles Bibliográficos
Autores principales: Eyre, T. A., Shah, N. N., Le Gouill, S., Dreyling, M., Vandenberghe, E., Jurczak, W., Wang, Y., Cheah, C. Y., Gandhi, M., Chay, C., Sharman, J. P., Andorsky, D. J., Yin, M., Balbas, M., Kherani, J., Wang, M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430278/
http://dx.doi.org/10.1097/01.HS9.0000847268.67095.fc
_version_ 1784779716273635328
author Eyre, T. A.
Shah, N. N.
Le Gouill, S.
Dreyling, M.
Vandenberghe, E.
Jurczak, W.
Wang, Y.
Cheah, C. Y.
Gandhi, M.
Chay, C.
Sharman, J. P.
Andorsky, D. J.
Yin, M.
Balbas, M.
Kherani, J.
Wang, M. L.
author_facet Eyre, T. A.
Shah, N. N.
Le Gouill, S.
Dreyling, M.
Vandenberghe, E.
Jurczak, W.
Wang, Y.
Cheah, C. Y.
Gandhi, M.
Chay, C.
Sharman, J. P.
Andorsky, D. J.
Yin, M.
Balbas, M.
Kherani, J.
Wang, M. L.
author_sort Eyre, T. A.
collection PubMed
description
format Online
Article
Text
id pubmed-9430278
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94302782022-08-31 P1100: BRUIN MCL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR CHOICE OF BTK INHIBITOR IN PATIENTS WITH PREVIOUSLY TREATED, BTK INHIBITOR NAÏVE MCL (TRIAL IN PROGRESS) Eyre, T. A. Shah, N. N. Le Gouill, S. Dreyling, M. Vandenberghe, E. Jurczak, W. Wang, Y. Cheah, C. Y. Gandhi, M. Chay, C. Sharman, J. P. Andorsky, D. J. Yin, M. Balbas, M. Kherani, J. Wang, M. L. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430278/ http://dx.doi.org/10.1097/01.HS9.0000847268.67095.fc Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Eyre, T. A.
Shah, N. N.
Le Gouill, S.
Dreyling, M.
Vandenberghe, E.
Jurczak, W.
Wang, Y.
Cheah, C. Y.
Gandhi, M.
Chay, C.
Sharman, J. P.
Andorsky, D. J.
Yin, M.
Balbas, M.
Kherani, J.
Wang, M. L.
P1100: BRUIN MCL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR CHOICE OF BTK INHIBITOR IN PATIENTS WITH PREVIOUSLY TREATED, BTK INHIBITOR NAÏVE MCL (TRIAL IN PROGRESS)
title P1100: BRUIN MCL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR CHOICE OF BTK INHIBITOR IN PATIENTS WITH PREVIOUSLY TREATED, BTK INHIBITOR NAÏVE MCL (TRIAL IN PROGRESS)
title_full P1100: BRUIN MCL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR CHOICE OF BTK INHIBITOR IN PATIENTS WITH PREVIOUSLY TREATED, BTK INHIBITOR NAÏVE MCL (TRIAL IN PROGRESS)
title_fullStr P1100: BRUIN MCL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR CHOICE OF BTK INHIBITOR IN PATIENTS WITH PREVIOUSLY TREATED, BTK INHIBITOR NAÏVE MCL (TRIAL IN PROGRESS)
title_full_unstemmed P1100: BRUIN MCL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR CHOICE OF BTK INHIBITOR IN PATIENTS WITH PREVIOUSLY TREATED, BTK INHIBITOR NAÏVE MCL (TRIAL IN PROGRESS)
title_short P1100: BRUIN MCL-321: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS INVESTIGATOR CHOICE OF BTK INHIBITOR IN PATIENTS WITH PREVIOUSLY TREATED, BTK INHIBITOR NAÏVE MCL (TRIAL IN PROGRESS)
title_sort p1100: bruin mcl-321: a phase 3 open-label, randomized study of pirtobrutinib vs investigator choice of btk inhibitor in patients with previously treated, btk inhibitor naïve mcl (trial in progress)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430278/
http://dx.doi.org/10.1097/01.HS9.0000847268.67095.fc
work_keys_str_mv AT eyreta p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT shahnn p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT legouills p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT dreylingm p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT vandenberghee p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT jurczakw p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT wangy p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT cheahcy p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT gandhim p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT chayc p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT sharmanjp p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT andorskydj p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT yinm p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT balbasm p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT kheranij p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress
AT wangml p1100bruinmcl321aphase3openlabelrandomizedstudyofpirtobrutinibvsinvestigatorchoiceofbtkinhibitorinpatientswithpreviouslytreatedbtkinhibitornaivemcltrialinprogress

Ejemplares similares